Similar articles

• Measurement of clinical response to anti-inflammatory drug therapy in rheumatoid arthritis.

  Deodhar SD, Dick WC, Hodgkinson R, Buchanan WW. Deodhar SD, et al. Q J Med. 1973 Apr;42(166):387-401. Q J Med. 1973. PMID: 4594449 Clinical Trial. No abstract available.
• [Method for initial evaluation of the action of antiinflammatory agents in rheumatoid arthritis].

  Bonollo L, Acocella G, Manzini A, Marchetti M, Nicolis FB. Bonollo L, et al. Boll Chim Farm. 1972 Jan;111(1):35-46. Boll Chim Farm. 1972. PMID: 4555648 Clinical Trial. Italian. No abstract available.
• The clinical evaluation of anti-arthritic drugs.

  Ward JR. Ward JR. Int J Clin Pharmacol. 1972 Apr;6(1):40-6. Int J Clin Pharmacol. 1972. PMID: 4558784 Clinical Trial. No abstract available.
• Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee.

  Tugwell P, Boers M. Tugwell P, et al. J Rheumatol. 1993 Mar;20(3):555-6. J Rheumatol. 1993. PMID: 8478872 Review. No abstract available.
• OMERACT and the clinical evaluation of new therapeutic agents: a bird's eye view. OMERACT Committee.

  Strand V. Strand V. J Rheumatol. 1993 Mar;20(3):588-9. J Rheumatol. 1993. PMID: 8478881 Review. No abstract available.